Thrombocytopenia (Thrombopenia) Summary

Networked: 18073 relevant articles (842 outcomes, 1156 trials/studies) for this Disease

Key Drugs and Agents for Thrombocytopenia

1. Heparin (Liquaemin) : 90 outcomes 174 studies in 3572 results : FDA 74 Generic
   
2. Inosine Triphosphate (ITP) : 90 outcomes 136 studies in 1382 results : IBA
   
3. Immunoglobulins (Immunoglobulin) : 35 outcomes 12 studies in 325 results : IBA
   
4. Intravenous Immunoglobulins (IVIG) : 32 outcomes 16 studies in 173 results : FDA 1
   
5. Antibodies : 28 outcomes 71 studies in 1162 results : IBA
   
6. eltrombopag : 26 outcomes 35 studies in 150 results : FDA 1
   
7. rituximab (Mabthera) : 25 outcomes 17 studies in 178 results : FDA 3
   
8. Immunoglobulin G (IgG) : 24 outcomes 33 studies in 549 results : IBA
   
9. Thrombopoietin (c-mpl Ligand) : 22 outcomes 49 studies in 272 results : IBA
   
10. Adrenal Cortex Hormones (Corticosteroids) : 21 outcomes 8 studies in 149 results : IBA
    

Diseases Related to Thrombocytopenia

1. Hemorrhage
2. Anemia
3. Leukopenia
4. Neutropenia
5. Infection

Key Therapies for Thrombocytopenia

1. Splenectomy : 81 outcomes 30 studies in 576 results
   
2. Drug Therapy (Chemotherapy) : 69 outcomes 100 studies in 834 results
   
3. Platelet Transfusion (Blood Platelet Transfusions) : 23 outcomes 36 studies in 494 results
   
4. Plasma Exchange : 18 outcomes 1 study in 96 results
   
5. Renal Dialysis (Hemodialysis) : 8 outcomes 5 studies in 132 results